{"id":380716,"date":"2020-10-21T11:16:02","date_gmt":"2020-10-21T15:16:02","guid":{"rendered":"https:\/\/patientworthy.wpengine.com\/2020\/10\/21\/nuevo-tratamiento-covid-19-ingresa-a-ensayo-de-fase-3\/"},"modified":"2020-10-21T11:17:10","modified_gmt":"2020-10-21T15:17:10","slug":"nuevo-tratamiento-covid-19-ingresa-a-ensayo-de-fase-3","status":"publish","type":"post","link":"https:\/\/patientworthy.com\/es\/2020\/10\/21\/nuevo-tratamiento-covid-19-ingresa-a-ensayo-de-fase-3\/","title":{"rendered":"Nuevo Tratamiento COVID-19 Ingresa a Ensayo de Fase 3"},"content":{"rendered":"<p>Grifols, una compa\u00f1\u00eda farmac\u00e9utica con sede en Barcelona, Espa\u00f1a, ha anunciado que su posible tratamiento para el nuevo coronavirus ha entrado en un ensayo de fase 3, <a href=\"https:\/\/www.biospace.com\/article\/releases\/grifols-anti-sars-cov-2-hyperimmune-globulin-begins-clinical-trial-in-patients-with-covid-19\/?s=86\">seg\u00fan BioSpace<\/a>. Se lleva a cabo en colaboraci\u00f3n con varias agencias federales de EE. UU., Como los NIH. La intenci\u00f3n del ensayo es evaluar la seguridad, tolerabilidad y eficacia.<\/p>\n<h2>Acerca del Estudio<\/h2>\n<p>Este ensayo evaluar\u00e1 la hiperinmune globulina anti-SARS-CoV-2 de Grifols, que proporciona una concentraci\u00f3n alta y constante de anticuerpos neutralizantes. Los creadores del medicamento creen que podr\u00eda ayudar a prevenir y tratar el COVID-19. Creen que si se administra cuando se notan los s\u00edntomas por primera vez, podr\u00eda cambiar la respuesta natural de los anticuerpos del cuerpo y reducir la posibilidad de un caso grave y la muerte.<\/p>\n<p>El ensayo en s\u00ed es multic\u00e9ntrico, internacional, aleatorizado, controlado con placebo, doble ciego y adaptativo. 500 adultos que se encuentran en hospitales en 18 pa\u00edses recibir\u00e1n globulina hiperinmune anti-SARS-CoV-2 en combinaci\u00f3n con remdesivir o un placebo y remdesivir.<\/p>\n<p>Si este ensayo finaliza con \u00e9xito, Grifols ha afirmado que est\u00e1 preparado para producir grandes vol\u00famenes del tratamiento en poco tiempo. Tambi\u00e9n est\u00e1n trabajando en otras 25 iniciativas para combatir COVID-19, muchas de las cuales utilizan tratamientos existentes para tratar el virus. Tienen la esperanza de que no solo su estudio de Fase 3 de globulina hiperinmune anti-SARS-CoV-2 termine con \u00e9xito, sino que sus otros ensayos tambi\u00e9n lo hagan.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Grifols, una compa\u00f1\u00eda farmac\u00e9utica con sede en Barcelona, Espa\u00f1a, ha anunciado que su posible tratamiento para el nuevo coronavirus ha entrado en un ensayo de fase 3, seg\u00fan BioSpace. Se lleva a cabo en colaboraci\u00f3n con varias agencias federales de EE. UU., Como los NIH. La intenci\u00f3n del ensayo es evaluar la seguridad, tolerabilidad y [&hellip;]<\/p>\n","protected":false},"author":1025,"featured_media":205476,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ocean_front_end_style_editor":"no","ocean_post_layout":"","ocean_both_sidebars_style":"","ocean_both_sidebars_content_width":0,"ocean_both_sidebars_sidebars_width":0,"ocean_sidebar":"0","ocean_second_sidebar":"0","ocean_disable_margins":"enable","ocean_add_body_class":"","ocean_shortcode_before_top_bar":"","ocean_shortcode_after_top_bar":"","ocean_shortcode_before_header":"","ocean_shortcode_after_header":"","ocean_has_shortcode":"","ocean_shortcode_after_title":"","ocean_shortcode_before_footer_widgets":"","ocean_shortcode_after_footer_widgets":"","ocean_shortcode_before_footer_bottom":"","ocean_shortcode_after_footer_bottom":"","ocean_display_top_bar":"default","ocean_display_header":"default","ocean_header_style":"","ocean_center_header_left_menu":"0","ocean_custom_header_template":"0","ocean_custom_logo":0,"ocean_custom_retina_logo":0,"ocean_custom_logo_max_width":0,"ocean_custom_logo_tablet_max_width":0,"ocean_custom_logo_mobile_max_width":0,"ocean_custom_logo_max_height":0,"ocean_custom_logo_tablet_max_height":0,"ocean_custom_logo_mobile_max_height":0,"ocean_header_custom_menu":"0","ocean_menu_typo_font_family":"0","ocean_menu_typo_font_subset":"","ocean_menu_typo_font_size":0,"ocean_menu_typo_font_size_tablet":0,"ocean_menu_typo_font_size_mobile":0,"ocean_menu_typo_font_size_unit":"px","ocean_menu_typo_font_weight":"","ocean_menu_typo_font_weight_tablet":"","ocean_menu_typo_font_weight_mobile":"","ocean_menu_typo_transform":"","ocean_menu_typo_transform_tablet":"","ocean_menu_typo_transform_mobile":"","ocean_menu_typo_line_height":0,"ocean_menu_typo_line_height_tablet":0,"ocean_menu_typo_line_height_mobile":0,"ocean_menu_typo_line_height_unit":"","ocean_menu_typo_spacing":0,"ocean_menu_typo_spacing_tablet":0,"ocean_menu_typo_spacing_mobile":0,"ocean_menu_typo_spacing_unit":"","ocean_menu_link_color":"","ocean_menu_link_color_hover":"","ocean_menu_link_color_active":"","ocean_menu_link_background":"","ocean_menu_link_hover_background":"","ocean_menu_link_active_background":"","ocean_menu_social_links_bg":"","ocean_menu_social_hover_links_bg":"","ocean_menu_social_links_color":"","ocean_menu_social_hover_links_color":"","ocean_disable_title":"default","ocean_disable_heading":"default","ocean_post_title":"","ocean_post_subheading":"","ocean_post_title_style":"","ocean_post_title_background_color":"","ocean_post_title_background":0,"ocean_post_title_bg_image_position":"","ocean_post_title_bg_image_attachment":"","ocean_post_title_bg_image_repeat":"","ocean_post_title_bg_image_size":"","ocean_post_title_height":0,"ocean_post_title_bg_overlay":0.5,"ocean_post_title_bg_overlay_color":"","ocean_disable_breadcrumbs":"default","ocean_breadcrumbs_color":"","ocean_breadcrumbs_separator_color":"","ocean_breadcrumbs_links_color":"","ocean_breadcrumbs_links_hover_color":"","ocean_display_footer_widgets":"default","ocean_display_footer_bottom":"default","ocean_custom_footer_template":"0","ocean_post_oembed":"","ocean_post_self_hosted_media":"","ocean_post_video_embed":"","ocean_link_format":"","ocean_link_format_target":"self","ocean_quote_format":"","ocean_quote_format_link":"post","ocean_gallery_link_images":"on","ocean_gallery_id":[]},"categories":[16333],"tags":[16300,19433,14397,14398],"_links":{"self":[{"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/posts\/380716"}],"collection":[{"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/users\/1025"}],"replies":[{"embeddable":true,"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/comments?post=380716"}],"version-history":[{"count":0,"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/posts\/380716\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/media\/205476"}],"wp:attachment":[{"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/media?parent=380716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/categories?post=380716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientworthy.com\/es\/wp-json\/wp\/v2\/tags?post=380716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}